Prognostic impact of repeat sentinel lymph node biopsy in patients with ipsilateral breast tumour recurrence
British journal of surgery2019Vol. 106(5), pp. 574–585
Citations Over Time
Ingrid G. M. Poodt, Guusje Vugts, Robert‐Jan Schipper, Rudi M. H. Roumen, H.J.T. Rutten, Adriana J. G. Maaskant-Braat, Adri C. Voogd, Grard A. P. Nieuwenhuijzen, Ernest J. T. Luiten, Emiel J. Rutgers, Marie-Jeanne T. F. D. Vrancken-Peeters, Maud Bessems, Joost M. Klaase, Sandra Müller, A.B. Francken, Thijs van Dalen, Leigh A. Jansen, S A Koopal, Yvonne L. J. Vissers, Marjolein L. Smidt, J. W. S. Merkus, Caroline M. E. Contant, P H Veldman, E. Linthorst-Niers, J R van der Sijp, Onno R. Guicherit, Linetta B. Koppert, Anne Marie Bosch, Luc J. A. Strobbe, Margrethe Schlooz-Vries, I E Arntz, Jeroen A. van Essen, J.W.D. de Waard, B. C. Vrouenraets, B van Ooijen
Abstract
The outcome of rSLNB is not an important prognostic factor for distant recurrence, and its value as a staging tool in patients with IBTR seems disputable.
Related Papers
- → Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes(2016)21 cited
- → Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery(2007)24 cited
- → Predictive factors of axillary positive sentinel lymph node biopsy in extended ductal carcinoma in situ treated by simple mastectomy at once(2019)6 cited
- Identification of Sentinel Lymph Node in Breast Cancer by Intro-dermal Methylthionium Injection(2004)
- → Hospital variation in the use of Sentinel Lymph Node Biopsy for patients with a biopsy diagnosis of ductal carcinoma in situ(2020)